Literature DB >> 19617258

Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS).

Weiping Jia1, Xin Gao, Can Pang, Xuhong Hou, Yuqian Bao, Wei Liu, Wenxia Wang, Yuhua Zuo, Huilin Gu, Kunsan Xiang.   

Abstract

BACKGROUND: Diabetes is a major risk factor for the development of kidney disease. We aimed to determine the prevalence of albuminuria and chronic kidney disease (CKD) in Chinese subjects with diabetes and pre-diabetes and the risk factors for kidney disease.
METHODS: An urban community-based sample of 3714 adults in Shanghai was classified into normal glucose tolerance (NGT), impaired glucose regulation (IGR) and diabetes. The estimated glomerular filtration rate (eGFR) and the urinary albumin-to-creatinine ratio (ACR) were applied to designate renal function and albuminuria, respectively. Binary logistic regression was performed to analyse the contribution of risk factors to CKD. Polynominal regression was used to determine the trends of eGFR with the increment of ACR.
RESULTS: The prevalence of microalbuminuria, macroalbuminuria and CKD in subjects with diabetes was 22.8%, 3.4% and 29.6%, respectively, which was significantly higher than that in non-diabetes subjects. After adjustment for age, the odds ratio of hypertension for albuminuria and renal insufficiency (eGFR <60 mL/min/1.73 m(2,) stages 3-5 of CKD) were 1.23 (P = 0.000) and 2.55 (P = 0.000). Diabetes and cardiovascular disease (CVD) both increased the risk for albuminuria significantly, with the odds ratio of 1.22 (P = 0.04) and 1.36 (P = 0.006), respectively. Diabetes and CVD were not independent risk factor for renal insufficiency. Although the worsening trends of eGFR are similar in diabetes and IGR subjects, IGR was not a significant risk factor for albuminuria and renal insufficiency.
CONCLUSION: Screening for albuminuria and eGFR is highly recommended for older patients with diabetes, hypertension and CVD to prevent end-stage kidney disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617258     DOI: 10.1093/ndt/gfp349

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  35 in total

1.  Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes.

Authors:  Danfeng Peng; Jie Wang; Rong Zhang; Feng Jiang; Shanshan Tang; Miao Chen; Jing Yan; Xue Sun; Shiyun Wang; Tao Wang; Dandan Yan; Yuqian Bao; Cheng Hu; Weiping Jia
Journal:  Diabetologia       Date:  2015-03-28       Impact factor: 10.122

2.  Prevalence of Chronic Kidney Disease among Patients Attending a Specialist Diabetes Clinic in Jamaica.

Authors:  T S Ferguson; M K Tulloch-Reid; N O Younger-Coleman; R A Wright-Pascoe; M S Boyne; A K Soyibo; R J Wilks
Journal:  West Indian Med J       Date:  2015-05-04       Impact factor: 0.171

3.  Hyperphosphatemia is associated with overt proteinuria in non-diabetic patients with late-stage chronic kidney disease: a cross-sectional study.

Authors:  Yit-Sheung Yap; Wen-Che Chi; Cheng-Hao Lin; Yi-Wen Wu; Yi-Chun Liu
Journal:  Int Urol Nephrol       Date:  2012-03-31       Impact factor: 2.370

Review 4.  The Prevalence of Diabetic Microvascular Complications in China and the USA.

Authors:  Yu Kuei Lin; Bixia Gao; Lili Liu; Lynn Ang; Kara Mizokami-Stout; Rodica Pop-Busui; Luxia Zhang
Journal:  Curr Diab Rep       Date:  2021-04-09       Impact factor: 4.810

Review 5.  Diabetes and its comorbidities--where East meets West.

Authors:  Alice P S Kong; Gang Xu; Nicola Brown; Wing-Yee So; Ronald C W Ma; Juliana C N Chan
Journal:  Nat Rev Endocrinol       Date:  2013-05-28       Impact factor: 43.330

6.  Factors related to nephrotic-range proteinuria in late-stage chronic kidney disease patients with diabetes mellitus.

Authors:  Yit-Sheung Yap; Hung-Yi Chuang; Wen-Che Chi; Cheng-Hao Lin; Yi-Wen Wu; Pai-Chun Chang; Yi-Chun Liu
Journal:  Int Urol Nephrol       Date:  2013-01-26       Impact factor: 2.370

7.  Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study.

Authors:  Antonio Rodriguez-Poncelas; Josep Garre-Olmo; Josep Franch-Nadal; Javier Diez-Espino; Xavier Mundet-Tuduri; Joan Barrot-De la Puente; Gabriel Coll-de Tuero
Journal:  BMC Nephrol       Date:  2013-02-22       Impact factor: 2.388

8.  Chronic kidney disease and associated cardiovascular risk factors in chinese with type 2 diabetes.

Authors:  Qing-Lin Lou; Xiao-Jun Ouyang; Liu-Bao Gu; Yong-Zhen Mo; Ronald Ma; Jennifer Nan; Alice Kong; Wing-Yee So; Gary Ko; Juliana Chan; Chun-Chung Chow; Rong-Wen Bian
Journal:  Diabetes Metab J       Date:  2012-12-12       Impact factor: 5.376

9.  Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study.

Authors:  Vijay Viswanathan; Priyanka Tilak; Satyavani Kumpatla
Journal:  Indian J Med Res       Date:  2012-07       Impact factor: 2.375

10.  Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area.

Authors:  Gabriel Coll-de-Tuero; Manel Mata-Cases; Antonio Rodriguez-Poncelas; Josep M A Pepió; Pilar Roura; Belen Benito; Josep Franch-Nadal; Marc Saez
Journal:  BMC Nephrol       Date:  2012-08-20       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.